Drugging the Undruggable with Greg Verdine
Greg Verdine, PhD, is a leader in the discovery, development, and commercialization of new drug modalities, a repeat founder, and the newest venture partner at a16z Bio + Health. He is joined by Vineeta Agarwala and Jorge Conde, general partners at a16z Bio + Health.
Raghu Raghurama16z.com
The Little Tech Agendaa16z.com
Engaging the Unengaged at Home with Max Cohen and Cameron Behara16z.com
Evolve or Die: The Future of the Creative Process, Artist Authenticity, and the Value of the Musica16z.com
The State of AI & Educationa16z.com
America's Energy Problem: The Grid That Built America Can’t Power Its Futurea16z.com
Meet our 2023 Marketing Operations MVP Award winnersZapier
CloudOpen Preview: Defining the Open Cloud Stack - Linux FoundationLinuxfoundation
Live From LinuxCon Europe: Linux Kernel Developers Panel - Linux FoundationLinuxfoundation
On the Job with a Linux Foundation Systems Administrator - Linux FoundationLinuxfoundation
Apple WWDC 2024, set for June 10-14, promises to be 'A(bsolutely) I(ncredible)'Techcrunch
Costanoa Venture Capital: A $100M Fund For Startups That Develop Cloud Services For BusinessTechcrunch
Apple CEO reportedly urged Texas' governor to ditch online child safety billTechcrunch
SELECT STAR Video Spotlight: A Happy Place for Devs and DataCockroachlabs
The Abyss of Ignorable: a Route into Chaos Testing from Starling BankInfoq
Greg Kroah-Hartman: Lessons for Developers from 20 Years of Linux Kernel WorkThenewstack
Greg Touhill steps down from federal CISO rolecyberscoop.com
Greg Touhill named first federal CISOcyberscoop.com
GDPR deadline looms: The price and penaltiescomputerworld.com
Countdown to the GDPR deadline: Are you ready?computerworld.com
